Calcium > Uses

Nutritional Supplement

Calcium

  • Healthy Pregnancy and New Baby

    Gestational Hypertension

    Supplementing with calcium may reduce the risk of gestational hypertension.
    Gestational Hypertension
    ×

    Calcium deficiency has been implicated as a possible cause of GH.1,2 In two preliminary studies, women who developed GH were found to have significantly lower dietary calcium intake than did pregnant women with normal blood pressure.3,4 Calcium supplementation has significantly reduced the incidence of GH in preliminary studies5 and in many,5,7,8,9,10,11 though not all,12 double-blind trials. Calcium supplements may be most effective in preventing GH in women who have low dietary intake of calcium. The National Institutes of Health (NIH) recommends an intake of 1,200 to 1,500 mg of calcium daily during normal pregnancy.13 In women at risk of GH, studies showing reduced incidence have typically used 2,000 mg of supplemental calcium per day,14,15,5,7,9,11 without any reported maternal or fetal side effects.14,15 Nonetheless, many doctors continue to suggest amounts no higher than 1,500 mg per day.

    Preeclampsia

    An analysis of double-blind trials found calcium supplementation to be highly effective in preventing preeclampsia.
    Preeclampsia
    ×

    Calcium deficiency has been associated with preeclampsia.15 In numerous controlled trials, oral calcium supplementation has been studied as a possible preventive measure.16 17 1819 While most trials have found a significant reduction in the incidence of preeclampsia with calcium supplementation,161722231925 One study reported that calcium supplementation reduced both the severity of preeclampsia and the mortality rate in the infants.18

    An analysis of double-blind trials46 found calcium supplementation to be highly effective in preventing preeclampsia. However, a large and well-designed double-blind trial and a critical analysis of six double-blind trials concluded that calcium supplementation did not reduce the risk of preeclampsia in healthy women at low risk for preeclampsia.27 For healthy, high-risk (in other words, calcium deficient) women, however, the data show a clear and statistically significant beneficial effect of calcium supplementation in reducing the risk of preeclampsia.2723183118333435191938 39 4041

    The National Institutes of Health recommends an intake of 1,200 to 1,500 mg of elemental calcium daily during normal pregnancy.42 In women at risk of preeclampsia, most trials showing reduced incidence have used 2,000 mg of supplemental calcium per day.17 Nonetheless, many doctors continue to suggest amounts no higher than 1,500 mg per day.

  • Women's Health

    Premenstrual Syndrome

    Calcium appears to reduce the risk of mood swings, bloating, headaches, and other PMS symptoms.
    Premenstrual Syndrome
    ×
     

    Women who consume more calcium from their diets are less likely to suffer severe PMS.33 A large double-blind trial found that women who took 1,200 mg per day of calcium for three menstrual cycles had a 48% reduction in PMS symptoms, compared to a 30% reduction in the placebo group.34 Other double-blind trials have shown that supplementing 1,000 mg of calcium per day relieves premenstrual symptoms.35,36

  • Digestive Support

    Lactose Intolerance

    As lactose-containing foods are among the best dietary sources of calcium, lactose-intolerant people may want to use calcium supplements as an alternative source.
    Lactose Intolerance
    ×

    Caution: Calcium supplements should be avoided by prostate cancer patients.

    Researchers have yet to clearly determine whether lactose-intolerant people absorb less calcium.37 As lactose-containing foods are among the best dietary sources of calcium, alternative sources of calcium (from beverages, foods, or supplements) are important for lactose-intolerant people. A typical amount of supplemental calcium is 1,000 mg per day.

  • Menstrual and PMS Support

    Premenstrual Syndrome

    Calcium appears to reduce the risk of mood swings, bloating, headaches, and other PMS symptoms.
    Premenstrual Syndrome
    ×
     

    Women who consume more calcium from their diets are less likely to suffer severe PMS.38 A large double-blind trial found that women who took 1,200 mg per day of calcium for three menstrual cycles had a 48% reduction in PMS symptoms, compared to a 30% reduction in the placebo group.39 Other double-blind trials have shown that supplementing 1,000 mg of calcium per day relieves premenstrual symptoms.40,41

  • Bone Support

    Osteoporosis

    Calcium supplements help prevent osteoporosis, especially for girls and premenopausal women. It is often recommended to help people already diagnosed with osteoporosis.
    Osteoporosis
    ×

    Caution: Calcium supplements should be avoided by prostate cancer patients.

    Although insufficient when used as the only intervention, calcium supplements help prevent osteoporosis.42 Though some of the research remains controversial, the protective effect of calcium on bone mass is one of very few health claims permitted on supplement labels by the U.S. Food and Drug Administration.

    In some studies, higher calcium intake has not correlated with a reduced risk of osteoporosis—for example, in women shortly after becoming menopausal43 or in men.44 However, after about three years of menopause, calcium supplementation does appear to take on a protective effect for women.45 Even the most positive trials using isolated calcium supplementation show only minor effects on bone mass. Nonetheless, a review of the research shows that calcium supplementation plus hormone replacement therapy is much more effective than hormone replacement therapy without calcium.46 Double-blind research has found that increasing calcium intake results in greater bone mass in girls.47 An analysis of many trials investigating the effects of calcium supplementation in premenopausal women has also shown a significant positive effect.48 Most doctors recommend calcium supplementation as a way to partially reduce the risk of osteoporosis and to help people already diagnosed with the condition. In order to achieve the 1,500 mg per day calcium intake many researchers deem optimal, 800 to 1,000 mg of supplemental calcium are generally added to the 500 to 700 mg readily obtainable from the diet.

    While phosphorus is essential for bone formation, most people do not require phosphorus supplementation, because the typical western diet provides ample or even excessive amounts of phosphorus. One study, however, has shown that taking calcium can interfere with the absorption of phosphorus, potentially leading to phosphorus deficiency in elderly people, whose diets may contain less phosphorus.49. The authors of this study recommend that, for elderly people, at least some of the supplemental calcium be taken in the form of tricalcium phosphate or some other phosphorus-containing preparation.

    One trial studying postmenopausal women combined hormone replacement therapy with magnesium (600 mg per day), calcium (500 mg per day), vitamin C, B vitamins, vitamin D, zinc, copper, manganese, boron, and other nutrients for an eight- to nine-month period.50 In addition, participants were told to avoid processed foods, limit protein intake, emphasize vegetable over animal protein, and limit consumption of salt, sugar, alcohol, coffee, tea, chocolate, and tobacco. Bone density increased a remarkable 11%, compared to only 0.7% in women receiving hormone replacement alone.

What Are Star Ratings?
×
Reliable and relatively consistent scientific data showing a substantial health benefit.
Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit.
For an herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support.

Our proprietary “Star-Rating” system was developed to help you easily understand the amount of scientific support behind each supplement in relation to a specific health condition. While there is no way to predict whether a vitamin, mineral, or herb will successfully treat or prevent associated health conditions, our unique ratings tell you how well these supplements are understood by the medical community, and whether studies have found them to be effective for other people.

For over a decade, our team has combed through thousands of research articles published in reputable journals. To help you make educated decisions, and to better understand controversial or confusing supplements, our medical experts have digested the science into these three easy-to-follow ratings. We hope this provides you with a helpful resource to make informed decisions towards your health and well-being.

Temp Title
×
Temp Text

References

1. Leela R, Yasodhara P, Ramaraju MBBS, Ramaraju LA. Calcium and magnesium in pregnancy. Nutr Res 1991;11:1231-6.

2. Prada JA, Ross R, Clark KE. Hypocalcemia and pregnancy-induced hypertension produced by maternal fasting. Hypertension 1992;20:620-6.

3. Marcous S, Brisson J, Fabia J. Calcium intake from dairy products and supplements and the risk of preeclampsia and gestational hypertension. Am J Epidemiol 1991;133:1226-72.

4. Ortega RM, Martinez RM, Lopez-Sobaler AM, et al. Influence of calcium intake on gestational hypertension. Ann Nutr Metab 1999;43:37-46.

5. Bucher HC, Guyatt GH, Cook RJ, et al. Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. JAMA 1996;275:1113-7.

6. Lopez-Jaramillo P, Narvaez M, Weigle RM, Yepez R. Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population. Br J Obstet Gynaecol 1989;96:648-55.

7. Cong K, Chi S, Lui G. Calcium supplementation during pregnancy for reducing pregnancy induced hypertension. Chin Med J 1995;108:57-9.

8. Purwar M, Kulkarni, H, Motghare V, Dhole S. Calcium supplementation and prevention of pregnancy induced hypertension. J Obstet Gynaecol Res 1996;22:425-30.

9. Belizan JM, Villar J, Gonzalez L. Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 1991;325:1399-405.

10. Sanchez-Ramos L, Briones DK, Kaunitz AM, et al. Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive patients. Obstet Gynecol 1994;84:349-53.

11. Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent preeclampsia. N Engl J Med 1997;337:69-76.

12. NIH Consensus Development Panel on Optimal Calcium Intake. Optimal calcium intake. Nutrition 1995;11:409-17.

13. Moutquin JM, Garner PR, Burrows RF, et al. Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy. CMAJ 1997;157:907-19.

14. Cong K, Chi S, Lui G. Calcium supplementation during pregnancy for reducing pregnancy induced hypertension. Chin Men J 1995;108:57-9.

15. 33. Hojo M, August P. Calcium metabolism in normal and hypertensive pregnancy. Semin Nephrol 1995;15:504-11 [review].

16. Hojo M, August P. Calcium Metabolism in Preeclampsia: Supplementation may help. Medscape Womens Health 1997;2:5.

17. Moutquin JM, Garner PR, Burrows RF, et al. Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy. CMAJ 1997;157:907-19.

18. Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent preeclampsia. N Engl J Med 1997;337:69-76.

19. Belizan JM, Villar J, Gonzalez L. Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 1991;325:1399-405.

20. Crowther CA, Hiller JE, Pridmore B, et al. Calcium supplementation in nulliparous women for the prevention of pregnancy-induced hypertension, preeclampsia, and preterm birth: an Australian randomized trial. FRACOG and the ACT study group. Aust N Z J Obstet Gynaecol 1999;39:12-8.

21. Bucher HC, Guyatt GH, Cook RJ, et al. Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. JAMA 1996;275:1113-7.

22. Herrera JA, Arevalo-Herrera M, Herrera S. Prevention of preeclampsia by linoleic acid and calcium supplementation: a randomized controlled trial. Obstet Gynecol 1998;91:585-90.

23. Villar J, Abdel-Aleem H, Merialdi M, et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gyneco 2006;194:639-49.

24. Sibai BM. Prevention of preeclampsia: A big disappointment. Am J Obstet Gynecol 1998;179:1275-8 [review].

25. Lopez-Jaramillo P, Narvaez M, Weigle RM, Yepez R. Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population. Br J Obstet Gynaecol 1989;96:648-55.

26. Lopez-Jaramillo P, Narvaez M, Felix C, Lopez A. Dietary calcium supplementation and prevention of pregnancy hypertension. Lancet 1990;335:293. [letter]

27. Villar J, Repke JT. Calcium supplementation during pregnancy may reduce preterm delivery in high-risk populations. Am J Obstet Gynecol 1990;163:1124-31.

28. Sanchez-Ramos L, Briones DK, Kaunitz AM, et al. Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive patients. Obstet Gynecol 1994;84:349-53.

29. DerSimonian R, Levine RJ. Resolving discrepancies between a meta-analysis and a subsequent large controlled trial. JAMA 1999;282:664-70 [review].

30. Ritchie LD, King JC. Dietary calcium and pregnancy-induced hypertension: is there a relation? Am J Clin Nutr 2000;71(5 Suppl):1371S-4S [review].

31. Villar J, Belizan JM. Same nutrient, different hypotheses: disparities in trials of calcium supplementation during pregnancy. Am J Clin Nutr 2000;71(5 Suppl):1375-9S [review].

32. Consensus Development Conference Panel. Optimal calcium intake: Consensus Development Conference statement. JAMA 1994;272:1942-8.

33. Rossignol AM, Bonnlander H. Premenstrual symptoms and beverage consumption. Am J Obstet Gynecol 1993;168:1640 [letter].

34. Thys-Jacobs S, Starkey P, Bernstein D, et al. Calcium carbonate and the premenstrual syndrome: Effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol 1998;179:444-52.

35. Thys-Jacobs S, Ceccarelli S, Bierman A, et al. Calcium supplementation in premenstrual syndrome. J Gen Intern Med 1989;4:183-9.

36. Penland J, Johnson P. Dietary calcium and manganese effects on menstrual cycle symptoms. Am J Obstet Gynecol 1993;168:1417-23.

37. Wheadon M, Goulding A, Barbezat GO, et al. Lactose malabsorption and calcium intake as risk factors for osteoporosis in elderly New Zealand women. NZ Med J 1991;104:417-9.

38. Rossignol AM, Bonnlander H. Premenstrual symptoms and beverage consumption. Am J Obstet Gynecol 1993;168:1640 [letter].

39. Thys-Jacobs S, Starkey P, Bernstein D, et al. Calcium carbonate and the premenstrual syndrome: Effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol 1998;179:444-52.

40. Thys-Jacobs S, Ceccarelli S, Bierman A, et al. Calcium supplementation in premenstrual syndrome. J Gen Intern Med 1989;4:183-9.

41. Penland J, Johnson P. Dietary calcium and manganese effects on menstrual cycle symptoms. Am J Obstet Gynecol 1993;168:1417-23.

42. Reid IR, Ames RW, Evans MC, et al. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am J Med 1995;98:331-5.

43. Hosking DJ, Ross PD, Thompson DE, et al. Evidence that increased calcium intake does not prevent early postmenopausal bone loss. Clin Ther 1998;20:933-44.

44. Owusu W, Willett WC, Feskanich D, et al. Calcium intake and the incidence of forearm and hip fractures among men. J Nutr 1997;127:1782-7.

45. Rulm LA, Sakhaee K, Peterson R, et al. The effect of calcium citrate on bone density in the early and mid-postmenopausal period: a randomized, placebo-controlled study. Am J Ther 1999;6:303-11.

46. Nieves JW, Komar L, Cosman F, Lindsay R. Calcium potentiates the effect of estrogen and calcitonin on bone mass: review and analysis. Am J Clin Nutr 1998;67:18-24.

47. Bonjour JP, Carrie AL, Ferrari S, et al. Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind, placebo-controlled trial. J Clin Invest 1997;99:1287-94.

48. Welten DC, Kemper HCG, Post GB, van Stavberen WA. A meta-analysis of the effect of calcium intake on bone mass in young and middle aged females and males. J Nutr 1995;125:2802-13 [review].

49. Heaney RP, Nordin BEC. Calcium effects on phosphorus absorption: implications for the prevention and co-therapy of osteoporosis.J Am Coll Nutr 2002;21:239-44.

50. Abraham GE, Grewal H. A total dietary program emphasizing magnesium instead of calcium. J Reprod Med 1990;35:503-7.

51. Sheikh MS, Santa Ana CA, Nicar MJ, et al. Gastrointestinal absorption of calcium from milk and calcium salts. N Engl J Med 1987;317:532–6.

52. Levenson DI, Bockman RS. A review of calcium preparations. Nutr Rev 1994;52:221-32 [review].

53. Gaby, AR. Nutritional Medicine. Concord, NH: Fritz Perlberg Publishing, 2011.

54. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride. Washington DC: National Academy Press, 1997, 108-17 [review].

55. Heaney RP, Recker RR, Weaver CM. Absorbability of calcium sources: the limited role of solubility. Calcif Tissue Int 1990;46:300-4.

56. Levenson DI, Bockman RS. A review of calcium preparations. Nutr Rev 1994;52:221-32 [review].

57. Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010;341:c3691.

58. Lewis JR, Calver J, Zhu K, et al. Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5-year follow-up. J Bone Miner Res 2011;26:35-41.

59. Rejnmark L, Avenell A, Masud T, et al. Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab 2012;May 17 [Epub ahead of print].

60. Burros M. Testing calcium supplements for lead. New York Times June 4, 1997, B7.

61. Bourgoin BP, Evans DR, Cornett JR, et al. Lead content in 70 brands of dietary calcium supplements. Am J Public Health 1993;83:1155-60.

62. Ross EA, Szabo NJ, Tebbett IR. Lead content of calcium supplements. JAMA 2000;284:1425-9.